• Study on IMA203 for Patients with Previously Treated Unresectable or Metastatic Skin Melanoma

    Recruiting

    3 1 1 1
    Investigated diseases:
    France Germany The Netherlands

  • Study on High-Dose Short-Course Antibiotics for Critically Ill Patients with Pneumonia, Intra-Abdominal, or Bloodstream Infections: Ceftriaxone, Linezolid, and Cefotaxime

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium The Netherlands

  • Study on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Relapsed or Refractory Mantle Cell Lymphoma

    Recruiting

    3 1
    Investigated diseases:
    Austria France Germany Italy Poland Spain

  • Study on the Effects of ILB and Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    2 1 1
    Norway

  • Study Comparing Belantamab Mafodotin with Lenalidomide and Dexamethasone to Daratumumab with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Czechia France Germany Greece +5

  • Study on Testosterone and Isopropyl Myristate for Women with Turner Syndrome

    Recruiting

    2 1 1
    Investigated diseases:
    Denmark

  • Study on Betamethasone Sodium Phosphate and Drug Combination for Pregnant Women with Preterm Premature Rupture of Membranes

    Recruiting

    3 1 1 1
    Investigated diseases:
    Czechia

  • Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

    Recruiting

    3 1 1
    Investigated diseases:
    Belgium Bulgaria Czechia Denmark France Germany +9

  • Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments

    Recruiting

    3 1
    Investigated diseases:
    Bulgaria Czechia Denmark Germany Hungary Italy +3

  • Study on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Investigated diseases:
    Austria Belgium Denmark Estonia Finland France +8

powered by